English court says Roche did not infringe insulin pump patents

The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Roche asks court for halt of Novartis unit’s generic launch

4 April 2022 Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.

Big Pharma

Roche and Bluebird settle ‘Spark’ TM suit

19 May 2022 Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.

Americas

Swiss big pharma settles patent dispute with Insulet

12 July 2022 The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.

More on this story

Big Pharma

Roche asks court for halt of Novartis unit’s generic launch

4 April 2022 Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.

Americas

Swiss big pharma settles patent dispute with Insulet

12 July 2022 The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.

Big Pharma

Roche and Bluebird settle ‘Spark’ TM suit

More on this story

Big Pharma

Roche asks court for halt of Novartis unit’s generic launch

4 April 2022 Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.

Americas

Swiss big pharma settles patent dispute with Insulet

12 July 2022 The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.

Big Pharma

Roche and Bluebird settle ‘Spark’ TM suit